ArticleThe Journal of pediatrics2026
Association Between Salivary Substance P and Aspiration on Videofluoroscopic Swallow Study in Infants and Toddlers.
Article in The Journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo determine the association between salivary substance P (SP) concentration and aspiration on videofluoroscopic swallow study (VFSS) in children with oropharyngeal dysphagia. STUDY
designWe recruited children younger than 2 years of age who underwent VFSS within 3 months of study enrollment. Saliva samples were collected using absorbent collection devices and SP levels were measured by enzyme-linked immunosorbent immunoassays. We used the Student t test to compare levels between subjects with and without aspiration. Exploratory receiver operating characteristic analyses were used to determine optimal cut-off values and calculate sensitivity and specificity compared with gold-standard VFSS results. A subgroup analysis included only subjects with saliva collected within 1 month of VFSS.
resultsThe cohort included 50 subjects with age 8.16 ± 0.83 months at sample collection. SP concentrations were 344.7 ± 42.9 pg/mL for patients with aspiration compared with 105.7 ± 40.5 pg/mL for those without aspiration (P < .001). On receiver operating characteristic analysis, the area under the curve was 0.868 (95% CI 0.721-1.0, P < .001). A cutoff of 65 pg/mL provided 97% sensitivity (95% CI 86%-99%) and 75% specificity (95% CI 43%-95%) for predicting aspiration on VFSS. In a subgroup analysis with 29 subjects who had VFSS within 1 month of sample collection, the area under the curve was 0.964 (95% CI 0.98-1.0, P < .001). A cutoff of 63.2 pg/mL provided 100% sensitivity (95% CI 85%-100%) and 83.3% specificity (95% CI 36%-100%) for predicting aspiration on VFSS.
conclusionsSalivary SP concentrations were found to be significantly greater in children with aspiration. Salivary SP may represent an early candidate biomarker that could be used to predict risk of aspiration in infants and toddlers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.